LUNDBECK PHARMA A/S
CVR: 56750215
Lundbeck Pharma A/S has shown a positive trajectory in its financial health, with a notable increase in revenue from 15,968,000 DKK in 2023 to 18,343,000 DKK in 2024, alongside a significant rise in profit from 991,000 DKK to 1,820,000 DKK. The company's equity has also improved, reaching 3,484,000 DKK, indicating a recovery from previous years of negative equity. Despite a challenging period in 2020, the consistent growth in revenue and profit over the past two years reflects a strengthening position within the pharmaceutical distribution industry. However, ongoing attention to maintaining profit margins and managing any potential debt will be crucial for sustained growth.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 24.2.1958
Details
- Employees
- 17 employees
- 17 FTE
- (2018)
- Capital
- 500.000 kr.
Contact
- Phone
- Log in to see
Purpose
Selskabets formål er at drive handelsvirksomhed med human medicin samt, efter bestyrlsens skøn, anden i forbindelse dermed stående virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 18.3 mio. | 1.8 mio. | 19.6 mio. | 3.5 mio. | 20 | |
History
Ownership
Management
Directors
Board
Production units (2)
Similar companies
Companies in the same industry and area